INEOS announces plans to build a fourth hand sanitiser plant.
- New plant to open within the next ten days in Etain, North East France.
- INEOS also announces that it has delivered on its ten day promise and has started French production of one million bottles of hand sanitiser a month at its Lavera site.
- Hand sanitisers are a critical weapon in the fight against the Corona virus and remain in short supply across the France and Europe.
- Sister plants are all now in full production in UK, Germany and France.
- The INEOS Board has had a daily call on the progress of building the plants.
- Sir Jim Ratcliffe, founder and chairman of INEOS says, “I am extremely proud of the INEOS team who have already built three production facilities in literally a few days, with a fourth following next week. I believe these hand sanitisers will play a key role in the fight against the Coronavirus and will help protect hospital front line staff who deserve all the help we can give them.”
The company has also announced that it has met its ten-day target to build a hand sanitiser plant in Lavera France and has today started production of 1 million hand sanitisers a month.
Hand to mouth contamination is one of the main ways that the Coronavirus infects people and there is a critical shortage of hand sanitisers across France and the rest of Europe.
INEOS is focusing on meeting the needs of front line medical and care services as well as making “pocket bottle” hand sanitisers available for people’s personal use. These will be produced to World Health Organisation (WHO) specifications.
Sir Jim Ratcliffe, founder and chairman of INEOS says, “Now that production of the INEOS hand sanitiser has started, we are working on the fastest way to get them to where they need to be. I am confident that within a few days our sanitiser will start to be seen in hospitals, surgeries and people’s homes”.
INEOS is the leading European producer of the two key raw materials needed for sanitisers – isopropyl alcohol (IPA) and ethanol, producing almost 1 million tonnes. The company is already running these plants flat out and have been diverting more of this product to essential medical use including in the new INEOS factories.
INEOS takes its corporate and social responsibilities extremely seriously. Its products are essential to the production of essential healthcare products from rubber gloves, to PVC saline drips, syringes, ventilators, medical tubing. Its products purify the public’s drinking water. It produces raw materials for soap, phenol for aspirin and paracetamol, and its acetonitrile is being used in pharmaceutical analysis essential in procedures necessary to find a vaccine.
Sir Jim Ratcliffe, founder and chairman of INEOS adds, “INEOS is a company with enormous resources and manufacturing skills. If we can find other ways to help in the Coronavirus battle, we are absolutely committed to playing our part”
For more information please go to our website: www.ineoshandgel.com
Latest news
New Biostoom waste-to-energy plant delivers steam and electricity to Borealis in Beringen, Belgium
New state-of-the-art power station transforms non-recyclable waste from local households into electricity and steam. Successful first deliveries of steam and electricity to Borealis Beringen operat...
Yara ready to enable the hydrogen economy with historic full-scale green ammonia project in Porsgrunn, Norway
Yara announces plans for 500,000 tonnes per annum green ammonia production in Norway, powering emission-free shipping fuels and decarbonized food solutions. Yara plans to broaden its core, by enabl...
Construction of Clariant's sunliquid® plant in Podari, Romania on track for completion by the end of 2021
Construction continues with over 650 workers on site operating in full compliance with all COVID-19 pandemic precaution measurements. Majority of large key production equipment has already been ins...
New production facility for aromatic ring chlorination in Frankfurt-Höchst, Germany
WeylChem Group of Companies (WCGC), announced the larger scale investment in a new production facility for aromatic ring chlorination to be built at the Group’s site in Frankfurt-Höchst
